Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience

Clinics in Liver Disease
Mei Hwei Chang

Abstract

Prevention is most cost effective toward successful control of hepatitis B virus (HBV) infection and its complications. It is particularly urgent where HBV infection and hepatocellular carcinoma (HCC) are prevalent. To achieve better results of primary HCC prevention globally, higher world coverage rates of HBV vaccine, better strategies against breakthrough infection/nonresponder, and good long-term protection are needed. With the universal hepatitis B vaccination program starting from neonates in most countries, HBV infection and its complications will be further reduced in this century. An effective decline in the incidence of HCC in adults is expected in the near future. The concept of a cancer preventive vaccine, using HBV as an example, can be applied further to other infectious agents and their related cancers.

References

Apr 10, 1975·The New England Journal of Medicine·C E StevensW C Lee
Feb 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M H ChangD S Chen
May 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S D LeeM J Tong
Sep 18, 1996·JAMA : the Journal of the American Medical Association·H L ChenD S Chen
Sep 17, 1998·The Journal of Pediatrics·J R TangM H Chang
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H Y HsuH L Chen
Dec 15, 2000·Vaccine·Y PoovorawanS Chunsuttiwat
Dec 21, 2000·JAMA : the Journal of the American Medical Association·M H ChangUNKNOWN Taiwan Childhood Hepatoma Study Group
Jan 1, 2003·The Journal of Infectious Diseases·Yu-Cheng LinDing-Shinn Chen
Jan 31, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Huey-Ling ChenMei-Hwei Chang
Mar 12, 2004·The New England Journal of Medicine·Don Ganem, Alfred M Prince
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chun-Yi LuChin-Yun Lee
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mei-Hwei ChangUNKNOWN Taiwan Childhood HCC Study Group
Jun 7, 2006·Epidemiologic Reviews·Colin W ShepardBeth P Bell
Jan 31, 2009·Journal of Pediatric Gastroenterology and Nutrition·Wei-Ju SuPo-Huang Lee
Feb 4, 2009·Best Practice & Research. Clinical Gastroenterology·Daniel Lavanchy
Feb 4, 2009·Best Practice & Research. Clinical Gastroenterology·Koen Van HerckP Van Damme
Apr 7, 2009·Annals of Epidemiology·R Palmer Beasley
Sep 18, 2009·Journal of the National Cancer Institute·Mei-Hwei ChangUNKNOWN Taiwan Hepatoma Study Group

❮ Previous
Next ❯

Citations

Jan 19, 2012·QJM : Monthly Journal of the Association of Physicians·G NebbiaM K Maini
Dec 17, 2014·Seminars in Oncology·Harald zur Hausen, Ethel-Michele de Villiers
Jul 18, 2012·Seminars in Pediatric Surgery·Joshua N Honeyman, Michael P La Quaglia
Jan 18, 2011·Current Opinion in Immunology·Wolf Herman FridmanJérôme Galon
Oct 22, 2014·Pediatrics International : Official Journal of the Japan Pediatric Society·Kentaro IwasawaTomoo Fujisawa
Apr 7, 2015·Seminars in Oncology·Harald Zur Hausen, Ethel-Michele de Villiers
Jul 27, 2020·Pediatric Gastroenterology, Hepatology & Nutrition·Fang-Ting Lu, Yen-Hsuan Ni
May 8, 2021·Health Security·Deliana KostovaRonald L Moolenaar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.